FDA Investigator Marcia A Worley

Marcia A Worley has inspections in 11 countries as of 06 Oct 2023. Marcia A Worley has collaborated with a combinined 3091 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
123
Last Inspection Date:
06 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100004487
Country:
United States of America, France, Latvia, Turkey, Czechia, Poland, Japan, Romania, Serbia, Italy, Ukraine
Co-Investigator(s):
Adam J Taylor, Adam R Cooke, Alan M Roberts, Alicia M Mozzachio, Allison C Hunter, Amanda S Zorn, Amina Bashir, Ana E Morales, Andrew A Leboeuf, Andrew R Wasko, Andria L Kuhlman, Anna M Brannen, Anthony R Ronga, Ashley L Reiber, Audrey Dela Cruz, Barbara D Wright, Barbara G Langer, Barbara M Frazier, Betsy C Galliher, Bonita S Chester, Bradley J Maunder, Brentley S Collins, Brian D Nicholson, Brian P Emanuel, Brian R Cronenwett, Brittany R Laymon, Bruce H Mccullough, Bryan L Mcguckin, CDR Thomas R Berry, PPh, Charles A Snipes, PhD, Chase S Baldwin, Chelsea W Lamm, Ching Jeyg Chang, Christina A Miller, Christina L Bigham, Christopher D Leach, Christopher T Middendorf, Clinton D Priestley, Clotia Cabbey Mensah, Colleen E Burke, Craig T Rybus, Cynthia F Kleppinger, MD, D'arbra R Blankenship, Daniel B Arrecis, Dariusz Galezowski, Darrell E Luedtke, Darren S Morgan, Debra Boyd Seale, Debra I Love, Debra L Boyd Seale, Dell S Moller, Devaughn Edwards, Donna F Campbell, Donna K Speer, Dr. Abhijit Raha, PhD, Dr. Cj George Chang, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Edwardstine J Reese, Elizabeth L Holmes, Elizabeth Ll Edwards, Eric S Pittman, Frederick M Lochner, Geoffrey K Kilili, Gilbert J Heidenblut, Gregory R Dill, Hugh M Mcclure, II, Hugh M Mecture, III, Ingrid A Zambrana, Irina Gaberman, James E Roberts, James P Duggan, James W Plucinski, Janet L Bowen, Jason F Chancey, Jeanne J Chiu, Jeanne J Thai, Jeanne M Morris, Jennifer A D'angelo, Jennifer C Adams, Jennifer C Johnson, Jennifer L Jager, Jennifer L Sheehan, Jerri E Lothrop, Jesse A Vazquez, Jocelyn C Turner, John A Iwen, John M Seale, Joseph A Morkunas, Joseph X Kaufman, Joshua M Adams, Karen Emasley Joseph, Karen M Cooper, Karen M Kondas, Kassa Ayalew, MD, Kathleen A Schelble, Kathleen S Tormey, Kathryn Suttling, Kristen E Szenderski, Kujtim Sadiku, Laine P Myers, Lakecha N Lewis, Larry F Hallberg, Latoya A Griffith, Lauren A Crivellone, Lauren R Collins, Laurie A Haxel, Leeterry Moore, Lequita M Mayhew, Liliya V Bubiy, Lisa Hayka, Lisa Haykay, Margaret Torres Vazquez, Maria Diaz, Marie Bbuen Bigornia, Mark I Kaspar, Mary E Storch, Matthew B Casale, Matthew R Buenconsejo, Michael F Skelly, PhD, Michele L Glendenning, Michelle D Haamid, Nicholas P Diorio, Nicole J Clausen, Nicole M Bell, Nicole S Williams, Norman K Starks, Pablo Alcantara, Paola S Barnett, Patricia A Mcilroy, Patrick E Gainer, Phillip M Pontikos, Phung Thien Nguyen, Rafael Padilla, Randy L Clarida, Raul Alicea, Richard W Berning, Robert K Linn, Rosanna M Goodrich, Rosemary A Sexton, Roy C Stephens, Russell K Riley, Ruth Smith, Samuel W Labinjo, Scott A Krause, Scott B Laufenberg, Seneca D Toms, Shalonda C Clifford, Shannon A Dinardo, Sonya M Edmonds, State Agency, Stefen D Mcmillan, Stephen J Kilker, Stephen K Kilker, Sullan, Susan D Yuscius, Susan W Ciani, Tamara M Qtami, Tara C Alcazar, Tara M Carolfi, Thomas W Nojek, Thunder N Dunkijacobs, Tracey L Harris, Victoria M Daddeo, Viviana Matta, William G Nelson, William R Weissinger, Yiyue Zhang (nmi), PhD, Yuanyuan Li, Yvette Mlacour Davis, Zerita White

Marcia A Worley's Documents

Publish Date Document Type Title
November, 2009 FDA 483 Berger, Daniel M.D. - Form 483, 2009-11-24
January, 2009 FDA 483 Response Geohas, Jeffrey G., MD - Form 483R, 2009-01-22
July, 2018 EIR Advarra, Inc. - EIR, 2018-07-25
February, 2011 FDA 483 Kathleen M. Mullane, D.O. - Form 483, 2011-02-01
August, 2019 EIR StageBio - EIR, 2019-08-12
November, 2013 EIR IIT Research Institute - EIR, 2013-11-20
June, 2014 EIR AbbVie Inc - EIR, 2014-06-06
July, 2015 EIR Kamran Ayub - EIR, 2015-07-08
July, 2017 FDA 483 Brenda L Wong MD - Form 483, 2017-07-05
June, 2011 FDA 483 Scott Smith - Form 483, 2011-07-15
February, 2011 EIR Kathleen M. Mullane, D.O. - EIR, 2011-02-01
January, 2009 EIR Geohas, Jeffrey G., MD - EIR, 2009-01-13
June, 2015 EIR Lopes, Demetrius K, MD - EIR, 2015-06-25
December, 2014 EIR Berger, Daniel M.D. - EIR, 2014-12-04
July, 2013 EIR Jennifer A. Tuazon - EIR, 2013-07-10
July, 2013 FDA 483 Response Jennifer A. Tuazon - Form 483R, 2013-07-25
November, 2009 EIR Berger, Daniel M.D. - EIR, 2009-11-24
February, 2011 FDA 483 Response Kathleen M. Mullane, D.O. - Form 483R, 2011-02-14
August, 2019 EIR Medpace Inc - EIR, 2019-08-27
July, 2015 FDA 483 Kamran Ayub - Form 483, 2015-07-08
December, 2014 FDA 483 Response Sookyong Koh, M.D. - Form 483R, 2015-01-13
June, 2013 EIR Mercy Hospital Medical Center IRB - EIR, 2013-06-13
April, 2010 EIR Greenbaum, Michael S., M.D. - EIR, 2010-04-29
November, 2013 FDA 483 IIT Research Institute - Form 483, 2013-11-20
April, 2009 FDA 483 Greenbaum, Michael S., M.D. - Form 483, 2009-04-17
July, 2013 FDA 483 Jennifer A. Tuazon - Form 483, 2013-07-10
February, 2017 EIR Medpace Reference Laboratories - EIR, 2017-02-15
July, 2019 EIR Davis Remington Inc - EIR, 2019-07-10
February, 2013 FDA 483 Response Southern IL Hosp. Services dba Memorial Hosp. Carbondale IRB - Form 483R, 2013-03-06
November, 2013 EIR Advocate Health Care IRB - EIR, 2013-11-08
June, 2013 FDA 483 Response Mercy Hospital Medical Center IRB - Form 483R, 2013-06-27
February, 2016 EIR AbbVie Inc - EIR, 2016-02-04
September, 2019 EIR GlaxoSmithKline - EIR, 2019-09-12
February, 2009 FDA 483 Danny H. Sugimoto, M.D. - Form 483, 2009-02-23
August, 2018 EIR NAMSA, LLC - EIR, 2018-08-16
September, 2015 FDA 483 James N. Moy, M.D. - Form 483, 2015-09-30
April, 2017 EIR Battelle Memorial Institute - EIR, 2017-04-21
June, 2015 FDA 483 Response Lopes, Demetrius K, MD - Form 483R, 2015-12-18
December, 2014 FDA 483 Sookyong Koh, M.D. - Form 483, 2014-12-19
February, 2013 FDA 483 Southern IL Hosp. Services dba Memorial Hosp. Carbondale IRB - Form 483, 2013-02-15
June, 2016 FDA 483 Dr. Mimi Van Der Leden - Form 483, 2016-06-08
February, 2009 EIR Danny H. Sugimoto, M.D. - EIR, 2009-02-23
August, 2017 EIR Frontage Laboratories, Inc. - EIR, 2017-08-04
November, 2009 FDA 483 Response Berger, Daniel M.D. - Form 483R, 2010-01-11
November, 2019 EIR Battelle Memorial Institute - EIR, 2019-11-08
October, 2017 FDA 483 Michael L. Nordlund, MD, PhD - Form 483, 2017-10-18
February, 2009 FDA 483 Response Danny H. Sugimoto, M.D. - Form 483R, 2009-02-27
July, 2015 FDA 483 Response Kamran Ayub - Form 483R, 2015-07-08
June, 2013 FDA 483 Mercy Hospital Medical Center IRB - Form 483, 2013-06-13
March, 2018 EIR Frontage Laboratories, Inc. - EIR, 2018-03-08
June, 2015 FDA 483 Lopes, Demetrius K, MD - Form 483, 2015-06-25
March, 2019 EIR Matthew J. Matasar, M.D. - EIR, 2019-03-22
February, 2017 EIR Medpace Clinical Pharmacology, LLC - EIR, 2017-02-17
July, 2011 FDA 483 Xttrium Laboratories, Inc. - Form 483, 2011-07-18
April, 2009 FDA 483 Response Greenbaum, Michael S., M.D. - Form 483R, 2009-04-27
August, 2009 EIR St. Joseph Hospital Institutional Review Board - EIR, 2009-08-19
February, 2013 EIR Southern IL Hosp. Services dba Memorial Hosp. Carbondale IRB - EIR, 2013-02-15
August, 2009 FDA 483 St. Joseph Hospital Institutional Review Board - Form 483, 2009-08-19
December, 2014 EIR Sookyong Koh, M.D. - EIR, 2014-12-19
August, 2009 FDA 483 Response St. Joseph Hospital Institutional Review Board - Form 483R, 2009-09-03
April, 2009 EIR Greenbaum, Michael S., M.D. - EIR, 2009-04-17
January, 2009 FDA 483 Geohas, Jeffrey G., MD - Form 483, 2009-01-13

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more